Analysis of IBD Biologics public use with active Bio-Manguinhos/Fiocruz Productive Development Partnerships agreements (2018-2022)

Puntos clave

• The study aims to evaluate the public use of IBD biologics during the partnerships between Bio-Manguinhos and Fiocruz.
• Analysis of IBD biologics usage from 2018 to 2022.
• Involvement in an international symposium organized by Bio-Manguinhos.
• Findings presented at the International Symposium on Immunobiologicals.